Beneficial effect of Mentha suaveolens essential oil in the treatment of vaginal candidiasis assessed by real-time monitoring of infection

BMC Complementary and Alternative Medicine

Volumn 11, Issue , 2011, Pages

  Pietrella, Donatella ^a   Angiolella, Letizia ^b   Vavala, Elisabetta ^b   Rachini, Anna ^a   Mondello, Francesca ^c   Ragno, Rino ^d   Bistoni, Francesco ^a   Vecchiarelli, Anna ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; ECHINOCANDIN; ESSENTIAL OIL; FLUCONAZOLE; HERBACEOUS AGENT; JASMINE OIL; MENTHA SUAVEOLENS ESSENTIAL OIL; MICAFUNGIN; SODIUM CHLORIDE; TEA TREE OIL; UNCLASSIFIED DRUG; PLANT EXTRACT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDA ALBICANS; CONTROLLED STUDY; FEMALE; FUNGUS HYPHAE; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INFECTION PREVENTION; MENTHA; MENTHA SUAVEOLENS; MOUSE; NONHUMAN; SURVIVAL; VAGINA CANDIDIASIS; YEAST; ANIMAL; CHEMISTRY; DISEASE MODEL; DRUG EFFECT; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MOUSE STRAIN; NONPARAMETRIC TEST; PHYTOTHERAPY;

ANIMALS; ANTIFUNGAL AGENTS; CANDIDA ALBICANS; CANDIDIASIS, VULVOVAGINAL; DISEASE MODELS, ANIMAL; FEMALE; MENTHA; MICE; MICE, INBRED STRAINS; MICROBIAL SENSITIVITY TESTS; OILS, VOLATILE; PHYTOTHERAPY; PLANT EXTRACTS; STATISTICS, NONPARAMETRIC;

EID: 79952059078     PISSN: None     EISSN: 14726882     Source Type: Journal    
DOI: 10.1186/1472-6882-11-18     Document Type: Article

References (32)

1. Calderone RA, . (ed) Candida and Candidiasis. 2002, Washington, D.C.: ASM Press, (ed).
2. Odds FC, . (ed) Candida and Candidosis. 1988, London, United Kingdom: Bailliere Tindall, 2, (ed).
3. Sobel JD. Vulvovaginal candidosis. Lancet 2007, 369(9577):1961-1971. 10.1016/S0140-6736(07)60917-9, 17560449.
4. Sullivan DJ, Moran GP, Pinjon E, Al-Mosaid A, Stokes C, Vaughan C, Coleman DC. Comparison of the epidemiology, drug resistance mechanisms, and virulence of Candida dubliniensis and Candida albicans. FEMS Yeast Res 2004, 4(4-5):369-376. 10.1016/S1567-1356(03)00240-X, 14734017.
5. Cowan MM. Plant products as antimicrobial agents. Clin Microbiol Rev 1999, 12(4):564-582. 88925, 10515903.
6. Stockwell C, . (ed) Nature's pharmacy. 1988, London, UK: Century Hutchinson Ltd, (ed).
7. Thomson WAR, . (ed) Medicines from Hearth. 1978, Maidenhead, UK: McGraw-Hill Book Co, (ed).
8. Arweiler NB, Donos N, Netuschil L, Reich E, Sculean A. Clinical and antibacterial effect of tea tree oil--a pilot study. Clin Oral Investig 2000, 4(2):70-73. 10.1007/s007840050118, 11218503.
9. Calcabrini A, Stringaro A, Toccacieli L, Meschini S, Marra M, Colone M, Salvatore G, Mondello F, Arancia G, Molinari A. Terpinen-4-ol, the main component of Melaleuca alternifolia (tea tree) oil inhibits the in vitro growth of human melanoma cells. J Invest Dermatol 2004, 122(2):349-360. 10.1046/j.0022-202X.2004.22236.x, 15009716.
10. Martin KW, Ernst E. Herbal medicines for treatment of fungal infections: a systematic review of controlled clinical trials. Mycoses 2004, 47(3-4):87-92. 10.1046/j.1439-0507.2003.00951.x, 15078424.
11. Bakkali F, Averbeck S, Averbeck D, Idaomar M. Biological effects of essential oils--a review. Food Chem Toxicol 2008, 46(2):446-475. 10.1016/j.fct.2007.09.106, 17996351.
12. Moreno L, Bello R, Primo-Yufera E, Esplugues J. Pharmacological properties of the methanol extract from Mentha suaveolens Ehrh. Phytother Res 2002, 16(Suppl 1):S10-13. 10.1002/ptr.744, 11933132.
13. Oumzil H, Ghoulami S, Rhajaoui M, Ilidrissi A, Fkih-Tetouani S, Faid M, Benjouad A. Antibacterial and antifungal activity of essential oils of Mentha suaveolens. Phytother Res 2002, 16(8):727-731. 10.1002/ptr.1045, 12458474.
14. Enjalbert B, Rachini A, Vediyappan G, Pietrella D, Spaccapelo R, Vecchiarelli A, Brown AJ, d'Enfert C. A multifunctional, synthetic Gaussia princeps luciferase reporter for live imaging of Candida albicans infections. Infect Immun 2009, 77(11):4847-4858. 10.1128/IAI.00223-09, 2772526, 19687206.
15. Angiolella LVE, Sivric S, Diodata D'AF, Ragno R. In vitro activity of Mentha suaveolens essential oil against Cryptococcus neoformans and dermatophytes. International Journal of Essential Oil Therapeutics 2010, 4(1-2):35-36.
16. Mondello F, De Bernardis F, Girolamo A, Cassone A, Salvatore G. In vivo activity of terpinen-4-ol, the main bioactive component of Melaleuca alternifolia Cheel (tea tree) oil against azole-susceptible and -resistant human pathogenic Candida species. BMC Infect Dis 2006, 6:158. 10.1186/1471-2334-6-158, 1637110, 17083732.
17. Rosato A, Vitali C, Gallo D, Balenzano L, Mallamaci R. The inhibition of Candida species by selected essential oils and their synergism with amphotericin B. Phytomedicine 2008, 15(8):635-638. 10.1016/j.phymed.2008.05.001, 18579358.
18. Agarwal V, Lal P, Pruthi V. Prevention of Candida albicans biofilm by plant oils. Mycopathologia 2008, 165(1):13-19. 10.1007/s11046-007-9077-9, 17968673.
19. Angiolella L, Stringaro AR, De Bernardis F, Posteraro B, Bonito M, Toccacieli L, Torosantucci A, Colone M, Sanguinetti M, Cassone A, et al. Increase of virulence and its phenotypic traits in drug-resistant strains of Candida albicans. Antimicrob Agents Chemother 2008, 52(3):927-936. 10.1128/AAC.01223-07, 2258496, 18180350.
20. Cassone A, Mason RE, Kerridge D. Lysis of growing yeast-form cells of Candida albicans by echinocandin: a cytological study. Sabouraudia 1981, 19(2):97-110.
21. NCCLS (ed) National Committee for Clinical Laboratory Standards. Methods for broth dilution antifungal susceptibility testing of yeast. 2008, 27-A3. Villanova, Pa., USA: NCCLS documents, Thirty, approved standard edn, NCCLS (ed).
22. Klepser ME, Ernst EJ, Lewis RE, Ernst ME, Pfaller MA. Influence of test conditions on antifungal time-kill curve results: proposal for standardized methods. Antimicrob Agents Chemother 1998, 42(5):1207-1212. 105779, 9593151.
23. Fidel PL, Lynch ME, Sobel JD. Candida-specific Th1-type responsiveness in mice with experimental vaginal candidiasis. Infect Immun 1993, 61(10):4202-4207. 281145, 8406809.
24. Pietrella D, Rachini A, Torosantucci A, Chiani P, Brown AJ, Bistoni F, Costantino P, Mosci P, d'Enfert C, Rappuoli R, et al. A beta-glucan-conjugate vaccine and anti-beta-glucan antibodies are effective against murine vaginal candidiasis as assessed by a novel in vivo imaging technique. Vaccine 2010, 28(7):1717-1725. 10.1016/j.vaccine.2009.12.021, 20038431.
25. Levy SB, Marshall B. Antibacterial resistance worldwide: causes, challenges and responses. Nat Med 2004, 10(12 Suppl):S122-129. 10.1038/nm1145, 15577930.
26. Perea S, Patterson TF. Antifungal resistance in pathogenic fungi. Clin Infect Dis 2002, 35(9):1073-1080. 10.1086/344058, 12384841.
27. Mondello F, De Bernardis F, Girolamo A, Salvatore G, Cassone A. In vitro and in vivo activity of tea tree oil against azole-susceptible and -resistant human pathogenic yeasts. J Antimicrob Chemother 2003, 51(5):1223-1229. 10.1093/jac/dkg202, 12668571.
28. Koliopoulos G, Pitarokili D, Kioulos E, Michaelakis A, Tzakou O. Chemical composition and larvicidal evaluation of Mentha, Salvia, and Melissa essential oils against the West Nile virus mosquito Culex pipiens. Parasitol Res 2010,
29. Yigit D, Yigit N, Ozgen U. An investigation on the anticandidal activity of some traditional medicinal plants in Turkey. Mycoses 2009, 52(2):135-140. 10.1111/j.1439-0507.2008.01552.x, 18522697.
30. Cassone A, De Bernardis F, Santoni G. Anticandidal immunity and vaginitis: novel opportunities for immune intervention. Infect Immun 2007, 75(10):4675-4686. 10.1128/IAI.00083-07, 2044548, 17562759.
31. Xu J, Schwartz K, Bartoces M, Monsur J, Severson RK, Sobel JD. Effect of antibiotics on vulvovaginal candidiasis: a MetroNet study. J Am Board Fam Med 2008, 21(4):261-268. 10.3122/jabfm.2008.04.070169, 18612052.
32. Magliani W, Conti S, Cassone A, De Bernardis F, Polonelli L. New immunotherapeutic strategies to control vaginal candidiasis. Trends Mol Med 2002, 8(3):121-126. 10.1016/S1471-4914(01)02268-7, 11879772.